Exploring CRISPR-Cas Systems for Genetic Disorders

Authors

  • Nico Harris Prof.
  • Skyler Scott Dr.
  • Nico Martinez PhD

Keywords:

CRISPR-Cas, Genetic Disorders, Genome Editing, Ethical Considerations, Clinical Trials

Abstract

CRISPR-Cas technology has revolutionized the field of genetic engineering, offering precise tools for genome editing. This article examines its application in correcting genetic disorders, reviewing recent advancements and ethical considerations. The authors discuss the potential and challenges of CRISPR-Cas systems in clinical settings.
This is a preliminary version. To read the full version of the article, please purchase a subscription.

Author Biographies

Nico Harris, Prof.

Prof.
University of Barcelona
Barcelona, 08007, Spain

Skyler Scott, Dr.

Dr.
Karolinska Institute
Stockholm, SE-171 77, Sweden

Nico Martinez, PhD

PhD
University of Cape Town
Rondebosch, Cape Town, 7700, South Africa

References

Бакърджиев, И., Игнатова, И., Гешева, Д., Стефанова, К., & Георгиева, В. БИОФЛАВОНОИДИ В КОЗМЕТИКАТА.

Downloads

Published

2025-12-23

Issue

Vol. 3 No. 4 (2025)

Section

Articles